Link to this page
SNOMED CT, US Edition
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/SNOMEDCT/1303105003
http://purl.bioontology.org/ontology/SNOMEDCT/1303105003
|
|---|---|
| Preferred Name | Ertugliflozin (as ertugliflozin pidolate) 15 mg and sitagliptin (as sitagliptin phosphate) 100 mg oral tablet |
| Synonyms |
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | Ertugliflozin (as ertugliflozin pidolate) 15 mg and sitagliptin (as sitagliptin phosphate) 100 mg oral tablet
|
|---|---|
| altLabel | Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)
|
| Type ID |
900000000000003001
900000000000013009
|
| Semantic type UMLS property | |
| Has presentation strength numerator unit | |
| Effective time | 20240201
|
| cui | C4535698
|
| CTV3ID | XVMc1
|
| Has precise active ingredient | |
| PRESENTATION STRENGTH NUMERATOR VALUE |
#100~1
#15~2
|
| Has presentation strength denominator unit | |
| DEFINITION STATUS ID | 900000000000073002
|
| CASE SIGNIFICANCE ID | 900000000000448009
|
| tui | T200
|
| Has manufactured dose form | |
| Has basis of strength substance | |
| Active | 1
|
| PRESENTATION STRENGTH DENOMINATOR VALUE |
#1~1
#1~2
|
| notation | 1303105003
|
| Has unit of presentation | |
| type | |
| subClassOf | |
| Subset member |
900000000000497000~MAPTARGET~XVMc1
900000000000509007~ACCEPTABILITYID~900000000000548007
900000000000508004~ACCEPTABILITYID~900000000000548007
|
| COUNT OF BASE OF ACTIVE INGREDIENT | #2~0
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |